Glanbia plc (OTCMKTS:GLAPF – Get Free Report) was the target of a large increase in short interest in January. As of January 30th, there was short interest totaling 239,856 shares, an increase of 42.0% from the January 15th total of 168,892 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,398.6 days. Based on an average daily trading volume, of 100 shares, the short-interest ratio is currently 2,398.6 days.
Glanbia Stock Down 0.0%
GLAPF stock traded down $0.00 during trading hours on Monday, reaching $19.99. The stock’s 50-day moving average price is $17.94 and its 200-day moving average price is $16.90. Glanbia has a 1-year low of $11.25 and a 1-year high of $19.99.
Analyst Upgrades and Downgrades
Separately, Morgan Stanley reaffirmed an “overweight” rating on shares of Glanbia in a research report on Thursday, January 29th. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy”.
About Glanbia
Glanbia plc is a global nutrition group headquartered in Kilkenny, Ireland, with roots tracing back to the merger of Avonmore and Waterford agricultural cooperatives in 1997. The company is organized around two main divisions: Performance Nutrition, which focuses on sports and lifestyle-forward consumer products, and Glanbia Nutritionals, which supplies nutritional ingredients and custom formulation services to food, beverage and pharmaceutical customers.
Under its Performance Nutrition arm, Glanbia markets well-known brands of protein powders, bars and ready-to-drink beverages designed for athletes, fitness enthusiasts and wellness-focused consumers.
Read More
- Five stocks we like better than Glanbia
- Is Elon Preparing for a Silver Shock?
- When to buy gold (mathematically)
- Nvidia CEO Issues Bold Tesla Call
- Trump & Musk’s Secret Bet on Silver — Exposed
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.
